logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
R

Ryan D. Gentzler

university of virginia cancer center
H指数:25
被引数:4,320

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Brief Report: Central Nervous System Metastases After Chemoradiation Followed by Durvalumab for Unresectable Locally Advanced Non-Small Cell Lung Cancer

简报：对于不可切除的局部晚期非小细胞肺癌，在同步放化疗后接受度鲁瓦鲁单抗治疗出现中枢神经系统转移的情况。

Clinical Lung Cancer
IF3.3
2025-07-050
PREAI
John Sharp; Philip Young; Songzhu Zhao; Lai Wei; Sandip H. Patel; Mingjia Li; Jeremy Brownstein; Karl Haglund; Joshua Palmer; Raju Raval; Sasha Beyer; Logan Roof; Peter Shields; Kai He; Jacob Kaufman; Regan M. Memmott; Asrar Alahmadi; David P Carbone; Gregory A Otterson; Carolyn J Presley; Ryan D. Gentzler; Dwight H. Owen
Cabozantinib Plus Atezolizumab or Cabozantinib Alone in Patients With Advanced NSCLC Previously Treated With an Immune Checkpoint Inhibitor: Results From the Phase 1b COSMIC-021 Study

卡博替尼联合阿特珠单抗或单用卡博替尼治疗先前接受免疫检查点抑制剂治疗的晚期NSCLC患者: 1b COSMIC-021期研究的结果

JTO CLINICAL AND RESEARCH REPORTS
IF3.5
2024-10-011
OA
Neal, Joel W.; Santoro, Armando; Gonzalez-Cao, Maria; Lim, Farah Louise; Fang, Bruno; Gentzler, Ryan D.; Goldschmidt, Jerome; Khrizman, Polina; Proto, Claudia; Patel, Shiven; Puri, Sonam; V. Liu, Stephen; Massarelli, Erminia; Williamson, Denise; Schwickart, Martin; Scheffold, Christian; Andrianova, Svetlana; Felip, Enriqueta
Spatial colocalization and combined survival benefit of natural killer and CD8 T cells despite profound MHC class I loss in non-small cell lung cancer

尽管非小细胞肺癌中MHC I类损失严重，但自然杀伤细胞和CD8 T细胞的空间共定位和联合生存益处

JOURNAL FOR IMMUNOTHERAPY OF CANCER
IF10.6
2024-09-180
OAAI
Wessel, Remziye E.; Ageeb, Nardin; Obeid, Joseph M.; Mauldin, Ileana S.; Goundry, Kate A.; Hanson, Gabriel F.; Hossain, Mahdin; Lehman, Chad; Gentzler, Ryan D.; Wages, Nolan A.; Slingluff, Craig L., Jr.; Bullock, Timothy N. J.; Dolatshahi, Sepideh; Brown, Michael G.
Association between early endpoints and survival outcomes in neoadjuvant treatment of resectable non-small cell lung cancer (NSCLC): A multi-country retrospective study

可切除非小细胞肺癌（NSCLC）新辅助治疗中早期终点与生存结局的关联：一项多国回顾性研究

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Pulla, M. Provencio; Berry, L.; Quintana, M.; LeBlanc, T. W.; Mascaux, C.; Schabath, M.; Bestvina, C. M.; Tratt, M.; Mansfield, A. S.; Bates, M.; Gentzler, R. D.; Girard, N.; Couraud, S.; Tan, C. J.; Wislez, M.; Wei, B.; Calvet, C.; Berry, D. A.; Vo, L.; Stenehjem, D.
Dynamic Changes in Circulating Tumor Fraction as a Predictor of Real-World Clinical Outcomes in Solid Tumor Malignancy Patients Treated with Immunotherapy
ONCOLOGY AND THERAPY
IF3.2
2024-07-220
OAAI
Gentzler, Ryan D.; Guittar, John; Mitra, Akash; Iams, Wade T.; Driessen, Terri; Schwind, Regina; Stein, Michelle M.; Kaneva, Kristiyana; Hyun, Seung Won; Liu, Yan; Dugan, Adam J.; Vibat, Cecile Rose T.; Sangli, Chithra; Freaney, Jonathan; Rivers, Zachary; Feliciano, Josephine L.; Lo, Christine; Sasser, Kate; Ben-Shachar, Rotem; Nimeiri, Halla; Patel, Jyoti D.; Chaudhuri, Aadel A.
Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study

Amivantamab联合化疗联合或不联合lazertinib治疗奥希替尼治疗EGFR突变晚期NSCLC后疾病进展: III期MARIPOSA-2研究的主要结果

ANNALS OF ONCOLOGY
IF65.4
2024-01-01101
OA
Passaro, A.; Wang, J.; Wang, Y.; Lee, S. -H.; Melosky, B.; Shih, J. -Y.; Wang, J.; Azuma, K.; Juan-Vidal, O.; Cobo, M.; Felip, E.; Girard, N.; Cortot, A. B.; Califano, R.; Cappuzzo, F.; Owen, S.; Popat, S.; Tan, J. -l.; Salinas, J.; Tomasini, P.; Gentzler, R. D.; William, W. N.; Reckamp, K. L.; Takahashi, T.; Ganguly, S.; Kowalski, D. M.; Bearz, A.; MacKean, M.; Barala, P.; Bourla, A. B.; Girvin, A.; Greger, J.; Millington, D.; Withelder, M.; Xie, J.; Sun, T.; Shah, S.; Diorio, B.; Knoblauch, R. E.; Bauml, J. M.; Campelo, R. G.; Cho, B. C.
Amivantamab plus chemotherapy (with or without lazertinib) vs chemotherapy in EGFR-mutated advanced NSCLC after progression on osimertinib: MARIPOSA-2, a phase III, global, randomized, controlled trial
ANNALS OF ONCOLOGY
IF65.4
2023-10-016
OA
Passaro, A.; Cho, B. C.; Wang, Y.; Melosky, B.; Califano, R.; Lee, S-H.; Girard, N.; Reckamp, K. L.; Takahashi, T.; Felip, E.; Gentzler, R. D.; Popat, S.; William, W. Nassib, Jr.; Sun, T.; Shah, S.; Diorio, B.; Knoblauch, R. E.; Bauml, J. M.; Garcia-Campelo, M. R.; Wang, J.
A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer (vol 27, pg 2470, 2021)
CLINICAL CANCER RESEARCH
IF10.2
2021-09-011
OA
Monjazeb, Arta M.; Giobbie-Hurder, Anita; Lako, Ana; Thrash, Emily M.; Brennick, Ryan C.; Kao, Katrina Z.; Manuszak, Claire; Gentzler, Ryan D.; Tesfaye, Anteneh; Jabbour, Salma K.; Alese, Olatunji B.; Rahma, Osama E.; Cleary, James M.; Sharon, Elad; Mamon, Harvey J.; Cho, May; Streicher, Howard; Chen, Helen X.; Ahmed, Mansoor M.; Marino-Enriquez, Adrian; Kim-Schulze, Seunghee; Gnjatic, Sacha; Maverakis, Emanual; Marusina, Alina I.; Merleev, Alexander A.; Severgnini, Mariano; Pfaff, Kathleen L.; Lindsay, James; Weirather, Jason L.; Ranasinghe, Srinika; Spektor, Alexander; Rodig, Scott J.; Hodi, F. Stephen; Schoenfeld, Jonathan D.
Activity and Safety of Mobocertinib (TAK-788) in Previously Treated Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations from a Phase I/II Trial
CANCER DISCOVERY
IF33.3
2021-02-25175
OA
Riely, Gregory J.; Neal, Joel W.; Camidge, D. Ross; Spira, Alexander, I; Piotrowska, Zofia; Costa, Daniel B.; Tsao, Anne S.; Patel, Jyoti D.; Gadgeel, Shirish M.; Bazhenova, Lyudmila; Zhu, Viola W.; West, Howard L.; Mekhail, Tarek; Gentzler, Ryan D.; Nguyen, Danny; Vincent, Sylvie; Zhang, Steven; Lin, Jianchang; Bunn, Veronica; Jin, Shu; Li, Shuanglian; Janne, Pasi A.

研究方向

暂未获取到该数据
J
Jyoti D. Patel
H 指数:57论文数:511被引数:1.7万
R
Richard D. Hall
H 指数:20论文数:107被引数:1,604
K
Karen L. Reckamp
H 指数:63论文数:544被引数:2.9万
R
Rotem Ben‐Shachar
H 指数:15论文数:84被引数:734
S
Shadia I. Jalal
H 指数:40论文数:243被引数:9,524
H
Halla Nimeiri
H 指数:30论文数:218被引数:3,418
B
Byoung Chul Cho
H 指数:106论文数:1,592被引数:7.0万
J
Joel W. Neal
H 指数:55论文数:608被引数:1.9万
E
Enriqueta Felip
H 指数:129论文数:1,499被引数:11.1万
A
Antonio Passaro
H 指数:42论文数:224被引数:9,136